The Prostate Cancer Research Foundation, Rotterdam, Stichting Wetenschappelijk Onderzoek Prostaatkanker (SWOP), is an initiative of the Department of Urology of the Erasmus MC, the University and Medical Centre of Rotterdam, in The Netherlands. Its goal is the financial support of scientific research projects in the field of prostate cancer, as well as other cancers of the urinary tract.
Please be aware that the Rotterdam Prostate Cancer Risk Calculator for Android cannot be 100% accurate at predicting the presence or absence of prostate cancer. It is designed to help calculate your risk, not give a definitive diagnosis.
The Rotterdam Prostate Cancer Risk Calculator for Android provides a general risk calculation based on your PSA level and other information.
While knowing your PSA level is helpful, the decision to have a PSA test has to be taken seriously after weighing up all factors and discussing the implications with your GP or hospital doctor.
It is possible that prostate cancer will not be found even if you have an elevated PSA. However, it may be present even if your PSA level is low.
Your doctor may want to take further tests. If you have doubts or questions about your health, you should always contact your GP or hospital doctor. This is particularly important if you have questions which arise from the use of our prostate cancer risk calculator.
It cannot be ruled out that the way the Rotterdam Prostate Cancer Risk Calculator for Android is used, or the indications given by it, are interpreted in a manner that is not appropriate. The creators of the Rotterdam Prostate Cancer Risk Calculator for Android do not accept any responsibility in any respect.
The European Randomized Study of Screening for Prostate Cancer has published its 11-year follow-up results (New England Journal of Medicine, March 15 2012). Once again, they demonstrate that screening does significantly reduce death from prostate cancer. The latest study confirms that a man who undergoes PSA testing will have his risk of dying from prostate cancer reduced by 29%.
ERSPC is the world’s largest randomized prostate cancer screening study. It was designed to investigate whether early detection and treatment of prostate cancer might reduce disease-specific mortality and also help to identify men at risk. From 1992, the ERSPC study randomized 162,000 men, aged 55 to 69, across Europe to either a screening arm or a control group.
Designed and developed for Android by Nuno Azevedo of Ydeal.net Software
It is designed to promote the PI-RADS scoring system within the radiologic and urologic communities, to provide efficiency gains to radiologists in charge of prostate MRI, and to improve the accuracy of reports.
It can be useful to radiologists, urologists and medical students.
For any suggestion : contact : email@example.com
International Prostate Symptom Score calculator.
PSA Density, Velocity and Doubling time calculators.
Risk of Biopsy Detectable prostate cancer calculator.
Optimum number of prostate biopsy cores calculator.
Keeps record of PSA test results.
THIS WEB SITE IS NOT DESIGNED TO, AND DOES NOT, PROVIDE MEDICAL ADVICE. ALL CONTENT ("CONTENT"), INCLUDING TEXT, GRAPHICS, IMAGES AND INFORMATION AVAILABLE ON OR THROUGH THIS WEB SITE ARE FOR GENERAL INFORMATIONAL PURPOSES ONLY.
THE CONTENT IS NOT INTENDED TO BE A SUBSTITUTE FOR PROFESSIONAL MEDICAL ADVICE, DIAGNOSIS OR TREATMENT. NEVER DISREGARD PROFESSIONAL MEDICAL ADVICE, OR DELAY IN SEEKING IT, BECAUSE OF SOMETHING YOU HAVE READ ON THIS WEB SITE. NEVER RELY ON INFORMATION ON THIS WEB SITE IN PLACE OF SEEKING PROFESSIONAL MEDICAL ADVICE.
Borinfer LLC IS NOT RESPONSIBLE OR LIABLE FOR ANY ADVICE, COURSE OF TREATMENT, DIAGNOSIS OR ANY OTHER INFORMATION, SERVICES OR PRODUCTS THAT YOU OBTAIN THROUGH THIS SITE. YOU ARE ENCOURAGED TO CONFER WITH YOUR DOCTOR WITH REGARD TO INFORMATION CONTAINED ON OR THROUGH THIS WEB SITE. AFTER READING ARTICLES OR OTHER CONTENT FROM THIS WEB SITE, YOU ARE ENCOURAGED TO REVIEW THE INFORMATION CAREFULLY WITH YOUR PROFESSIONAL HEALTHCARE PROVIDER.
1. The ProstateCheck-App supports men above the age of 45 to check their individual prostate health.
2. The ProstateCheck-App helps you and your physician in the early detection of prostate cancer ensuring that overdiagnosis and overtreatment are prevented.
3. The ProstateCheck-App defines your prostate health as the probability to be free from cancer.
4. The ProstateCheck-App recommends to you and your physician your personalized maximum time frame until your next check up.
5. The ProstateCheck-App is based on the largest ever screening study performed in German speaking countries with a follow up time of 14 years.
6. Your personal results are available in pdf format.
7. The ProstateCheck-App is developed by the Prostate Cancer Research Foundation Switzerland.
The ProstateCheck-App is based on scientific data derived from the largest prostate cancer screening study ever performed in German speaking countries with more than 10'000 participants and a follow up time of 14 years.
This App provides you the necessary information on the disease frequency, on early detection and on the possible side effects of treatment. It gives you important recommendations about your prostate health and the maximum time frame until your next checkup.
Prostate in focus as a reference app on curing cancer and treatment procedures. This app is solely for educational & instructive purposes only. The app is ideal for all medical professionals, medical residents and interns, nurses, and medical students.
Best comprehensive overview covers the Prostate Cancer Symptoms. This app has been developed for everyone, all topics has been made to make it useful and interesting.
*** Don’t wait! Download this app and get the health tips and facts you need today! ***
Prostate Cancer Symptoms app feature:
- What Is Prostate Cancer?
- Prostate Cancer Symptoms
- Prostate Cancer or Enlarged Prostate?
- Uncontrollable Risk Factors
- Controllable Risk Factors
- Prostate Cancer Myths
*** Please Do Rate the APP and leave a reply on your valuable suggestions and improvements ***
This is a new and improved app with e-mail export as well as leakage/pad functionality.
- App Features -
Bladder Diary – This is used to track fluid intake and urinary output. Output can be measured with a container that can be purchased at your local drug store. Measurements are listed in cubic centimeters (cc). Thirty cc = 1 ounce.
AUA Symptom Score- This is a questionnaire designed to help men, in conjunction with their health care providers, assess their urinary symptoms and response to therapy.
PSA Tracker – PSA (prostate specific antigen) is a blood test that is used to screen for prostate cancer and monitor response to prostate cancer therapy. The tracker has a table and graph format to keep track of your PSA values.
Ronald L. Yap, M.D.
Concord Hospital Center for Urologic Care
Adjunct Assistant Professor of Surgery (Urology)
Dartmouth Medical School
The LeBaron Foundation and The Concord Hospital Trust